 | • レポートコード：MRC-IM30254 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥369,852 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥665,852 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年に832.3百万ドルであった世界の呼吸器合胞体ウイルス（RSV）診断市場規模が、2022年から2027年の間にCAGR 9.7％で成長し、2027年までに1,439.2百万ドルに達すると予測しています。本調査レポートでは、呼吸器合胞体ウイルス（RSV）診断の世界市場について総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（直接蛍光抗体（DFA）法、迅速抗原診断検査（RADT）、分子診断、クロマトグラフィーイムノアッセイ、画像診断）分析、エンドユーザー別（病院＆クリニック、研究室、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目をまとめています。なお、本書に掲載されている企業情報には、Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporationなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の呼吸器合胞体ウイルス（RSV）診断市場規模：製品別 - 直接蛍光抗体（DFA）法の市場規模 - 迅速抗原診断検査（RADT）の市場規模 - 分子診断の市場規模 - クロマトグラフィーイムノアッセイの市場規模 - 画像診断の市場規模 ・世界の呼吸器合胞体ウイルス（RSV）診断市場規模：エンドユーザー別 - 病院＆クリニックにおける市場規模 - 研究室における市場規模 - その他エンドユーザーにおける市場規模 ・世界の呼吸器合胞体ウイルス（RSV）診断市場規模：地域別 - 北米の呼吸器合胞体ウイルス（RSV）診断市場規模 - アジアの呼吸器合胞体ウイルス（RSV）診断市場規模 - 欧州の呼吸器合胞体ウイルス（RSV）診断市場規模 - 中南米の呼吸器合胞体ウイルス（RSV）診断市場規模 - 中東・アフリカの呼吸器合胞体ウイルス（RSV）診断市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global respiratory syncytial virus (RSV) diagnostics market size reached US$ 832.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,439.2 Million by 2027, exhibiting a growth rate (CAGR) of 9.7% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Respiratory syncytial virus (RSV) is a viral infection of the lungs and respiratory tract, which can cause asthma, hospitalization, pneumonia, repeated infections, middle ear infection, and death. It can be diagnosed using blood tests, chest x-rays, a swab of secretions, and pulse oximetry by checking for signs like lung inflammation, white blood cell (WBC) count, and oxygen levels in the blood. Some of the commonly available treatment options for RSV are over-the-counter (OTC) medications, intravenous (IV) fluids, humidified oxygen, mechanical ventilation, and inhaled bronchodilators.
Respiratory Syncytial Virus (RSV) Diagnostics Market Trends:
RSV infection can be more serious during the neonatal period as children under two years of age tend to develop severe respiratory symptoms. This, in confluence with the rising focus of parents on child medical care, represents one of the crucial factors fostering the growth of the market. Moreover, the high survival rates after early diagnosis and the easy availability of diagnostic modalities act as other growth-inducing factors. Apart from this, the improving healthcare infrastructure and favorable reimbursement policies for the treatment of hospitalized infants are also contributing to market growth. Furthermore, the advent of advanced techniques like bio- and nanotechnology is facilitating the development of modern detection systems for RSV, such as western blot, enzyme-linked immunosorbent assay (ELISA), direct immunofluorescence, and real-time polymerase chain reaction (PCR). Besides this, governing agencies of numerous countries are funding research and development (R&D) projects for the development of new therapeutics. Other factors projected to drive the market are the growing number of clinical vaccine trials, the escalating demand for in-vitro diagnostics, rising incidences of childhood pneumonia and the increasing adoption of molecular diagnostics.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global respiratory syncytial virus (RSV) diagnostics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product and end use.
Breakup by Product:
Direct Fluorescent Antibody (DFA) Method
Rapid Antigen Diagnostic Test (RADTs)
Molecular Diagnostics
Chromatographic Immunoassay
Diagnostic Imaging
Gel Microdroplets
Flow Cytometry
Others
Breakup by End Use:
Hospitals and Clinics
Laboratory
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Coris BioConcept, DiaSorin Molecular LLC (DiaSorin Inc), F. Hoffmann-La Roche AG, Merck KGaA, Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report:
How has the global respiratory syncytial virus (RSV) diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global respiratory syncytial virus (RSV) diagnostics market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global respiratory syncytial virus (RSV) diagnostics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Respiratory Syncytial Virus (RSV) Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Direct Fluorescent Antibody (DFA) Method
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Rapid Antigen Diagnostic Test (RADTs)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Molecular Diagnostics
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Chromatographic Immunoassay
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Diagnostic Imaging
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Gel Microdroplets
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Flow Cytometry
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by End Use
7.1 Hospitals and Clinics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Laboratory
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Abbott Laboratories
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Becton, Dickinson and Company
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 bioMérieux SA
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Bio-Rad Laboratories Inc.
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Coris BioConcept
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.6 DiaSorin Molecular LLC (DiaSorin Inc)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.7 F. Hoffmann-La Roche AG
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 SWOT Analysis
13.3.8 Merck KGaA
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Quest Diagnostics Incorporated
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Quidel Corporation
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Thermo Fisher Scientific Inc.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials
13.3.11.4 SWOT Analysis
Figure 2: Global: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016-2021
Figure 3: Global: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 4: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Product (in %), 2021
Figure 5: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by End Use (in %), 2021
Figure 6: Global: Respiratory Syncytial Virus Diagnostics Market: Breakup by Region (in %), 2021
Figure 7: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Respiratory Syncytial Virus Diagnostics (Direct Fluorescent Antibody-DFA Method) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Respiratory Syncytial Virus Diagnostics (Rapid Antigen Diagnostic Test-RADTs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Respiratory Syncytial Virus Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Respiratory Syncytial Virus Diagnostics (Chromatographic Immunoassay) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Respiratory Syncytial Virus Diagnostics (Diagnostic Imaging) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Respiratory Syncytial Virus Diagnostics (Gel Microdroplets) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Respiratory Syncytial Virus Diagnostics (Flow Cytometry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Respiratory Syncytial Virus Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Respiratory Syncytial Virus Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Respiratory Syncytial Virus Diagnostics (Laboratory) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Respiratory Syncytial Virus Diagnostics (Other End Uses) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: North America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: North America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: United States: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: United States: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Canada: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Canada: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Asia-Pacific: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: China: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: China: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Japan: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Japan: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: India: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: India: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: South Korea: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: South Korea: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Australia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Australia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Indonesia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Indonesia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Europe: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Europe: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Germany: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Germany: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: France: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: France: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: United Kingdom: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: United Kingdom: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Italy: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Italy: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Spain: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Spain: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Russia: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Russia: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Latin America: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Latin America: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Brazil: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Brazil: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Mexico: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Mexico: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market: Breakup by Country (in %), 2021
Figure 77: Middle East and Africa: Respiratory Syncytial Virus Diagnostics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Global: Respiratory Syncytial Virus Diagnostics Industry: SWOT Analysis
Figure 79: Global: Respiratory Syncytial Virus Diagnostics Industry: Value Chain Analysis
Figure 80: Global: Respiratory Syncytial Virus Diagnostics Industry: Porter's Five Forces Analysis